HIV/AIDS Clinical Trials in Phoenix

Showing 201-220 of 605 trials

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

NCT00125099

The purpose of this study is to evaluate whether the HIV vaccine VRC-HIVDNA009-00-VP will be safe in individuals who started antiretroviral therapy during acute HIV-1 infection. The study will also test whether the vaccine can increase the immune system function in these participants.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)21 participants

San Diego, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 3299 miles

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

NCT00006145

Cytomegalovirus (CMV) infection is a common opportunistic infection (OI) in HIV patients. The purpose of this study is to find out whether valganciclovir, an antiviral approved by the FDA for the treatment of CMV in the eye, is safe and effective in preventing CMV organ damage in people with HIV.

Cytomegalovirus InfectionsHIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)350 participantsStarted Aug 2000

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +54 more locations

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

HIV/AIDS Trials in Other Cities

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

A Study of HIV-Disease Development in Aging

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Other Conditions in Phoenix